Who owns ATHIRA PHARMA INC?
- Ticker: LONA
- CUSIP Number: 04746l203
Tip: Access positions for across all investors
Analyze quarterly positions in Athira Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Athira Pharma stock
Who bought or sold ATHIRA PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Perceptive Advisors | 1.9M | $17M | 0% | Jun 2026 |
|
| ADAR1 Capital Management | 777k | $7.1M | 7% | Jun 2026 |
|
| Acorn Capital Advisors | 635k | $5.8M | 0% | Jun 2026 |
|
| NEA Management Company | 464k | $4.3M | 0% | Jun 2026 |
|
| Commodore Capital | 464k | $4.3M | 0% | Jun 2026 |
|
| TCG Crossover Management | 464k | $4.3M | 0% | Jun 2026 |
|
| Spruce Street Capital | 394k | $3.6M | 100% | Jun 2026 |
|
| Kalehua Capital Management | 394k | $3.6M | 0% | Jun 2026 |
|
| Blackstone Group | 325k | $3.0M | 100% | Jun 2026 |
|
| Adage Capital Partners GP | 300k | $2.8M | 100% | Jun 2026 |
|
| Vanguard Capital Management | 275k | $2.5M | 41% | Jun 2026 |
|
| Seven Fleet Capital Management | 154k | $1.4M | -6% | Jun 2026 |
|
| Simplify Asset Management | 149k | $1.4M | 0% | Jun 2026 |
|
| Propel Bio Management | 149k | $1.4M | 0% | Jun 2026 |
|
| Geode Capital Management | 80k | $740k | 0% | Jun 2026 |
|
| BlackRock | 79k | $728k | 41% | Jun 2026 |
|
| Renaissance Technologies | 77k | $712k | 21% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 43k | $394k | 7% | Jun 2026 |
|
| Bank of America Corporation | 33k | $299k | 0% | Jun 2026 |
|
| Millennium Management | 33k | $298k | 2% | Jun 2026 |
|
| Laird Norton Tyee Trust | 22k | $201k | 0% | Jun 2026 |
|
| State Street Corporation | 16k | $168k | 52% | Mar 2026 |
|
| Dimensional Fund Advisors | 15k | $135k | 100% | Jun 2026 |
|
| Northern Trust | 14k | $132k | 0% | Jun 2026 |
|
| Two Sigma Investments | 13k | $122k | 0% | Jun 2026 |
|
| XTX Topco | 12k | $108k | 100% | Jun 2026 |
|
| Acadian Asset Management | 10k | $94k | 0% | Jun 2026 |
|
| Citadel Advisors | 10k | $92k | 100% | Jun 2026 |
|
| Advisor Group Holdings | 4.6k | $42k | -26% | Jun 2026 |
|
| Jpmorgan Chase & Co | 2.0k | $18k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 1.3k | $12k | 0% | Jun 2026 |
|
| Royal Bank of Canada | 844.00 | $8.0k | -62% | Jun 2026 |
|
| Morgan Stanley | 471.00 | $4.7k | 0% | Mar 2026 |
|
| Tower Research Capital | 438.00 | $4.0k | 100% | Jun 2026 |
|
| American Capital Advisory | 200.00 | $1.8k | 0% | Jun 2026 |
|
| UBS Group | 196.00 | $1.8k | -85% | Jun 2026 |
|
| Rothschild Investment | 150.00 | $1.4k | 0% | Jun 2026 |
|
| McIlrath & Eck | 82.00 | $843.001000 | 0% | Mar 2026 |
|
| Us Bancorp | 81.00 | $744.001200 | 0% | Jun 2026 |
|
| Global Retirement Partners | 52.00 | $477.001200 | 0% | Jun 2026 |
|
| Barclays | 42.00 | $386.001000 | 100% | Jun 2026 |
|
| Jones Financial Companies, L.L | 33.00 | $309.998700 | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 20.00 | $184.000000 | -13% | Jun 2026 |
|
| SBI Securities | 12.00 | $110.000400 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 6.00 | $55.000200 | 0% | Jun 2026 |
|
| Citigroup | 1.00 | $10.000000 | 100% | Mar 2026 |
|
Who sold out of Athira Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Annis Gardner Whiting Capital Advisors | Mar 2026 | 1.0k | $10k |
| Goss Wealth Management | Mar 2026 | 410.00 | $4.2k |